Covered recipient · General Payments record
HILORIE EDWARDS GARSIDE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,357.87
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $314.14 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $75.47 | 2 |
| ABBVIE INC. | $56.95 | 3 |
| Lilly USA, LLC | $36.94 | 2 |
| Janssen Pharmaceuticals, Inc | $32.91 | 2 |
| QOL Medical, LLC | $23.65 | 1 |
| PFIZER INC. | $19.83 | 1 |
| DEXCOM, INC. | $19.65 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.05 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.36 | 1 |
| Currax Pharmaceuticals LLC | $14.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.86 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107154654 | CMS |
| ABBVIE INC. | $13.85 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107154656 | CMS |
| ABBVIE INC. | $19.24 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107154658 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.36 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086292382 | CMS |
| Currax Pharmaceuticals LLC | $14.33 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089521858 | CMS |
| Dexcom, Inc. | $19.65 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153363104 | CMS |
| Janssen Pharmaceuticals, Inc | $16.94 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078222243 | CMS |
| Janssen Pharmaceuticals, Inc | $15.97 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078222253 | CMS |
| Lilly USA, LLC | $20.36 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135681161 | CMS |
| Lilly USA, LLC | $16.58 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135641122 | CMS |
| Novo Nordisk Inc | $57.94 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108567685 | CMS |
| Novo Nordisk Inc | $17.53 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108567821 | CMS |
| PFIZER INC. | $19.83 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131418103 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.05 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151167614 | CMS |
| QOL Medical, LLC | $23.65 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147711336 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.